About Forte

Forte team members

Forte Research Systems, Inc. has been developing specialized software for clinical research since 2000. The product family includes OnCore® Enterprise Research, Allegro® CTMS, and Overture® EDC. Forte provides complimentary blog articles, eBooks, webinars and more to support continuous learning on industry topics. With a strong belief in community and standards-based development, Forte also facilitates the Onsemble® community and the Allegro Community.

Learn more about our systems:

In August 2015, Forte launched a subsidiary, Nimblify, Inc., a clinical trials technology company. Nimblify’s offerings include Participant Payments, Research Resonance Network and the Protocol Calendar Exchange.

Our Corporate Culture

Our Core Values

We understand that in order to be successful, we must provide sustainable value to all our stakeholders: customers, team members, investors, partners, and our community. We embrace these four Core Values as the North Star guiding the pursuit of our purpose and mission in service of our stakeholders:

Collaborate We work as a team with integrity, loyalty, trust, and mutual respect to achieve superior results through open and honest 2-way communication
Pursue Excellence We pursue excellence by continuously improving and innovating in everything we do
Fulfill Commitments We take personal responsibility for our actions and fulfill commitments to fellow team members, customers, investors and service partners
Celebrate We make our journey enjoyable by taking time to celebrate our successes along the way

Our Mission

We will enhance and accelerate clinical research by providing specialized and interconnected systems for investigators, sites, CROs, sponsors, regulatory agencies, and consumers.

As a thought leader and preferred provider of innovative clinical research informatics solutions, we will contribute to the advancement of medical care and the continuous improvement of clinical research operations by supporting research compliance, patient safety, financial viability, and operational efficiency.